SRF Ltd
NSE: SRF BSE: 503806
₹2616.40
(0.12%)
Tue, 26 May 2026, 04:50 pm
Market Cap774.66B
PE Ratio42.26
Dividend0.34
- Overview
- Analysis
- Financials
- Ratios
- shareholding
- Technical Analysis
- Corporate Actions
- Peer Comparison
- About
- Company History
- Deals
- News
SRF Analysis
dividend
Pros
- Dividends paid are thoroughly covered by earnings (11.4x coverage).
- Dividends after 3 years are expected to be well covered by earnings (5.5x coverage).
Cons
- No dividend growth in 10 years.
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- SRF's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- SRF's dividend is below the markets top 25% of dividend payers in India (3.08%).
future
Pros
- SRF's earnings growth is expected to exceed the low risk savings rate of 7.2%.
- SRF's earnings are expected to increase by more than the low risk growth rate in 3 years time.
- Performance (ROE) is expected to be above the current IN Chemicals industry average.
- An improvement in SRF's performance (ROE) is expected over the next 3 years.
- SRF's revenue growth is expected to exceed the India market average.
Cons
- Cash flow for SRF is expected to increase but not above the 50% threshold in 2 years time.
- SRF's earnings are expected to grow by 14.4% yearly, however this is not considered high growth (20% yearly).
- SRF's earnings growth is positive but not above the India market average.
- SRF's earnings are expected to decrease over the next year.
- SRF's net income is expected to increase but not above the 50% threshold in 2 years time.
- SRF is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
- SRF's revenue is expected to increase but not above the 50% threshold in 2 years time.
- SRF's revenue is expected to grow by 15.4% yearly, however this is not considered high growth (20% yearly).
health
Pros
- SRF is profitable, therefore cash runway is not a concern.
- SRF is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (39.9%, greater than 20% of total debt).
- SRF's cash and other short term assets cover its long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (106% vs 66.2% today).
- Interest payments on debt are well covered by earnings (EBIT is 5.3x coverage).
Cons
- SRF's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Debt is not covered by short term assets, assets are 0.9x debt.
- SRF's level of debt (66.2%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
management
Pros
- The tenure for the SRF board of directors is about average.
- Ashish's remuneration is about average for companies of similar size in India.
- Ashish's compensation has been consistent with company performance over the past year, both up more than 20%.
- More shares have been bought than sold by SRF individual insiders in the past 3 months.
- The average tenure for the SRF management team is over 5 years, this suggests they are a seasoned and experienced team.
Cons
misc
Pros
Cons
- SRF has significant price volatility in the past 3 months.
past
Pros
- SRF's 1-year earnings growth exceeds its 5-year average (42.6% vs 19.1%)
- SRF's year on year earnings growth rate has been positive over the past 5 years.
- SRF used its assets more efficiently than the IN Chemicals industry average last year based on Return on Assets.
- SRF has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
- SRF's earnings growth has exceeded the IN Chemicals industry average in the past year (42.6% vs 9.1%).
Cons
- SRF has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
value
Pros
- SRF outperformed the Chemicals industry which returned 2.2% over the past year.
- SRF outperformed the Market in India which returned -14.5% over the past year.
Cons
- SRF's share price is below the future cash flow value, but not at a moderate discount (< 20%).
- SRF's share price is below the future cash flow value, but not at a substantial discount (< 40%).
- SRF is overvalued based on assets compared to the IN Chemicals industry average.
- SRF is poor value based on expected growth next year.
- SRF is overvalued based on earnings compared to the IN Chemicals industry average.
- SRF is overvalued based on earnings compared to the India market.
- NSEI:SRF is flat (0.5%) underperforming the Chemicals industry which returned 6.9% over the past month.
- NSEI:SRF is flat (0.5%) underperforming the market in India which returned 8% over the past month.